Foghorn Therapeutics Inc. (FHTX)

Foghorn Therapeutics Market Cap

Foghorn Therapeutics has a market cap or net worth of $233.69 million as of April 26, 2024. Its market cap has decreased by -21.61% in one year.

• Market Cap: 233.69M
• Enterprise Value: 33.20M
• 1-Year Change: -21.61%
• Ranking: #3552
• Category: Micro-Cap
• Stock Price: $5.49

Market Cap Chart

Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $233.69M, a decrease of -58.67%. That is a compound annual growth rate of -22.27%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2024	222.60M	0.36%
Apr 24, 2024	221.80M	1.00%
Apr 23, 2024	219.60M	2.14%
Apr 22, 2024	215.00M	-4.70%
Apr 19, 2024	225.60M	-4.16%
Apr 18, 2024	235.40M	-4.31%
Apr 17, 2024	246.00M	-4.17%
Apr 16, 2024	256.70M	-5.63%
Apr 15, 2024	272.00M	-13.87%
Apr 12, 2024	315.80M	-7.25%
Apr 11, 2024	340.50M	10.19%
Apr 10, 2024	309.00M	-2.95%
Apr 9, 2024	318.40M	4.33%
Apr 8, 2024	305.20M	0.99%
Apr 5, 2024	302.20M	0.70%
Apr 4, 2024	300.10M	-2.22%
Apr 3, 2024	306.90M	2.99%
Apr 2, 2024	298.00M	-1.81%
Apr 1, 2024	303.50M	6.27%
Mar 28, 2024	285.60M	6.85%
Mar 27, 2024	267.30M	3.44%
Mar 26, 2024	258.40M	2.22%
Mar 25, 2024	252.80M	-6.61%
Mar 22, 2024	270.70M	-3.22%
Mar 21, 2024	279.70M	1.23%

View and export this data all the way back to 2020. Sign Up Today.

Related Stocks

Company	Market Cap
Senseonics Holdings	228.19M
uniQure	227.23M
Ovid Therapeutics	226.27M
Auna S.A.	221.81M
Accuray	220.15M
G1 Therapeutics	218.72M
Generation Bio Co.	216.72M
Lineage Cell Therapeutics	214.93M